| Dr Javier Fernando Dieguez, MD | |
|
6700 W 9th Ave, Amarillo, TX 79106-1701 | |
| (806) 358-0200 | |
| (806) 356-5590 |
| Full Name | Dr Javier Fernando Dieguez |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 17 Years |
| Location | 6700 W 9th Ave, Amarillo, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497061527 | NPI | - | NPPES |
| 347739001 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | Q5175 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baptist St Anthony's Hospital | Amarillo, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bsa Amarillo Diagnostic Clinic Inc | 5294959433 | 22 |
| Bsa Hospital Llc | 6305090762 | 22 |
News Archive
Workplace wellness programs that offer employees a financial carrot for undergoing health screenings, sticking to exercise regimens or improving their cholesterol levels have long been controversial.
The use of mud or wet clay as a topical skin treatment or a poultice is a common practice in some cultures and the concept of using mud as medicine goes back to earliest times.
Kaleida Health's Gates Stroke Center (GSC) at the Gates Vascular Institute in Buffalo, N.Y., a world-class neurological and stroke care center, recently completed the second phase of its study analyzing the patient and fiscal benefits of using Toshiba America Medical System, Inc.'s Aquilion ONE CT system in diagnosing acute stroke.
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, will update preliminary data on the safety and clinical benefit of ADXS-HPV from an ongoing randomized Phase 2 trial of ADXS-HPV with or without cisplatin in Indian women with recurrent/refractory cervical cancer who have failed cytotoxic therapy in a poster titled "ADXS11-001 immunotherapy targeting HPV-E7: Preliminary survival data from a phase II study in Indian women with recurrent/refractory cervical cancer" at the 2012 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, IL, on Sunday, June 3, 2012.
Cross Country Healthcare, Inc. today reported revenue of $117.8 million in the second quarter ended June 30, 2010, and net income of $1.2 million, or $0.04 per diluted share. This compares to revenue of $149.0 million in the prior year quarter and net income of $2.3 million, or $0.07 per diluted share. Cash flow from operations for the second quarter of 2010 was $13.4 million.
› Verified 7 days ago
| Entity Name | Bsa Hospital Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609112069 PECOS PAC ID: 6305090762 Enrollment ID: O20130212000300 |
News Archive
Workplace wellness programs that offer employees a financial carrot for undergoing health screenings, sticking to exercise regimens or improving their cholesterol levels have long been controversial.
The use of mud or wet clay as a topical skin treatment or a poultice is a common practice in some cultures and the concept of using mud as medicine goes back to earliest times.
Kaleida Health's Gates Stroke Center (GSC) at the Gates Vascular Institute in Buffalo, N.Y., a world-class neurological and stroke care center, recently completed the second phase of its study analyzing the patient and fiscal benefits of using Toshiba America Medical System, Inc.'s Aquilion ONE CT system in diagnosing acute stroke.
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, will update preliminary data on the safety and clinical benefit of ADXS-HPV from an ongoing randomized Phase 2 trial of ADXS-HPV with or without cisplatin in Indian women with recurrent/refractory cervical cancer who have failed cytotoxic therapy in a poster titled "ADXS11-001 immunotherapy targeting HPV-E7: Preliminary survival data from a phase II study in Indian women with recurrent/refractory cervical cancer" at the 2012 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, IL, on Sunday, June 3, 2012.
Cross Country Healthcare, Inc. today reported revenue of $117.8 million in the second quarter ended June 30, 2010, and net income of $1.2 million, or $0.04 per diluted share. This compares to revenue of $149.0 million in the prior year quarter and net income of $2.3 million, or $0.07 per diluted share. Cash flow from operations for the second quarter of 2010 was $13.4 million.
› Verified 7 days ago
| Entity Name | Bsa Amarillo Diagnostic Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134559826 PECOS PAC ID: 5294959433 Enrollment ID: O20140610001061 |
News Archive
Workplace wellness programs that offer employees a financial carrot for undergoing health screenings, sticking to exercise regimens or improving their cholesterol levels have long been controversial.
The use of mud or wet clay as a topical skin treatment or a poultice is a common practice in some cultures and the concept of using mud as medicine goes back to earliest times.
Kaleida Health's Gates Stroke Center (GSC) at the Gates Vascular Institute in Buffalo, N.Y., a world-class neurological and stroke care center, recently completed the second phase of its study analyzing the patient and fiscal benefits of using Toshiba America Medical System, Inc.'s Aquilion ONE CT system in diagnosing acute stroke.
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, will update preliminary data on the safety and clinical benefit of ADXS-HPV from an ongoing randomized Phase 2 trial of ADXS-HPV with or without cisplatin in Indian women with recurrent/refractory cervical cancer who have failed cytotoxic therapy in a poster titled "ADXS11-001 immunotherapy targeting HPV-E7: Preliminary survival data from a phase II study in Indian women with recurrent/refractory cervical cancer" at the 2012 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, IL, on Sunday, June 3, 2012.
Cross Country Healthcare, Inc. today reported revenue of $117.8 million in the second quarter ended June 30, 2010, and net income of $1.2 million, or $0.04 per diluted share. This compares to revenue of $149.0 million in the prior year quarter and net income of $2.3 million, or $0.07 per diluted share. Cash flow from operations for the second quarter of 2010 was $13.4 million.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Javier Fernando Dieguez, MD Po Box 840020, Dallas, TX 75284-0020 Ph: (806) 358-0200 | Dr Javier Fernando Dieguez, MD 6700 W 9th Ave, Amarillo, TX 79106-1701 Ph: (806) 358-0200 |
News Archive
Workplace wellness programs that offer employees a financial carrot for undergoing health screenings, sticking to exercise regimens or improving their cholesterol levels have long been controversial.
The use of mud or wet clay as a topical skin treatment or a poultice is a common practice in some cultures and the concept of using mud as medicine goes back to earliest times.
Kaleida Health's Gates Stroke Center (GSC) at the Gates Vascular Institute in Buffalo, N.Y., a world-class neurological and stroke care center, recently completed the second phase of its study analyzing the patient and fiscal benefits of using Toshiba America Medical System, Inc.'s Aquilion ONE CT system in diagnosing acute stroke.
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, will update preliminary data on the safety and clinical benefit of ADXS-HPV from an ongoing randomized Phase 2 trial of ADXS-HPV with or without cisplatin in Indian women with recurrent/refractory cervical cancer who have failed cytotoxic therapy in a poster titled "ADXS11-001 immunotherapy targeting HPV-E7: Preliminary survival data from a phase II study in Indian women with recurrent/refractory cervical cancer" at the 2012 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, IL, on Sunday, June 3, 2012.
Cross Country Healthcare, Inc. today reported revenue of $117.8 million in the second quarter ended June 30, 2010, and net income of $1.2 million, or $0.04 per diluted share. This compares to revenue of $149.0 million in the prior year quarter and net income of $2.3 million, or $0.07 per diluted share. Cash flow from operations for the second quarter of 2010 was $13.4 million.
› Verified 7 days ago
James Edward Lusby, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 6700 W 9th Ave, Amarillo, TX 79106 Phone: 806-358-0200 Fax: 806-356-5590 | |
Henry David Bruton, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 6700 W 9th Ave, Amarillo, TX 79106 Phone: 806-358-0200 Fax: 806-356-5511 | |
Dr. Anjali Subhash Kherdekar, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 12 Care Cir, Amarillo, TX 79124 Phone: 806-353-7417 Fax: 806-353-4007 | |
James P.a. Yhip, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1660 Point West Pkwy, Amarillo, TX 79124 Phone: 806-510-4244 Fax: 806-510-7211 | |
Dr. Michael John Lamanteer, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1600 Wallace Blvd, Amarillo, TX 79106 Phone: 806-212-2129 Fax: 806-212-2246 | |
Thien Toan Vo, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1400 S Coulter St, Amarillo, TX 79106 Phone: 806-414-9100 Fax: 806-354-5717 | |
John Scott Milton, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1400 S Coulter St, Amarillo, TX 79106 Phone: 806-354-5480 Fax: 806-354-5764 |